🚀 VC round data is live in beta, check it out!
YSB Valuation Multiples
Discover revenue and EBITDA valuation multiples for YSB and similar public comparables like Haypp Group, Dimed SA, Nice One, BHG Group and more.
YSB Overview
About YSB
YSB Inc is a digital pharmaceutical platform serving businesses outside of hospitals in China. The Group mainly engaged in i) wholesales of pharmaceutical and healthcare products offline or online through its online platform; ii) retail of pharmaceutical and healthcare products through its retail shops; iii) operating online platform that enable the pharmaceutical distributors and vendors to sell their own pharmaceutical and healthcare products using the Group’s online platform; iv) providing SaaS solution to downstream pharmacies to streamline their inventory management; and v) providing medical testing services to primary healthcare institutions. The Group principally operates in the PRC and generates the majority of its revenues from the PRC.
Founded
2018
HQ
Employees
6.8K
Website
Financials (FY)
EV
$244M
YSB Financials
YSB reported last fiscal year revenue of $3B and EBITDA of $23M.
In the same fiscal year, YSB generated $266M in gross profit, $23M in EBITDA, and $2M in net income.
YSB P&L
In the most recent fiscal year, YSB reported revenue of $3B and EBITDA of $23M.
YSB expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | — | XXX | $3B | XXX | XXX | XXX |
| Gross Profit | — | XXX | $266M | XXX | XXX | XXX |
| Gross Margin | — | XXX | 10% | XXX | XXX | XXX |
| EBITDA | — | XXX | $23M | XXX | XXX | XXX |
| EBITDA Margin | — | XXX | 1% | XXX | XXX | XXX |
| EBIT Margin | — | XXX | (0%) | XXX | XXX | XXX |
| Net Profit | — | XXX | $2M | XXX | XXX | XXX |
| Net Margin | — | XXX | 0% | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
YSB Stock Performance
YSB has current market cap of $453M, and enterprise value of $244M.
Market Cap Evolution
YSB's stock price is $0.66.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $244M | $453M | 2.3% | XXX | XXX | XXX | $0.00 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialYSB Valuation Multiples
YSB trades at 0.1x EV/Revenue multiple, and 10.8x EV/EBITDA.
YSB Financial Valuation Multiples
As of April 18, 2026, YSB has market cap of $453M and EV of $244M.
Equity research analysts estimate YSB's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
YSB has a P/E ratio of 204.7x.
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $453M | XXX | $453M | XXX | XXX | XXX |
| EV (current) | $244M | XXX | $244M | XXX | XXX | XXX |
| EV/Revenue | — | XXX | 0.1x | XXX | XXX | XXX |
| EV/EBITDA | — | XXX | 10.8x | XXX | XXX | XXX |
| EV/EBIT | — | XXX | (19.9x) | XXX | XXX | XXX |
| EV/Gross Profit | — | XXX | 0.9x | XXX | XXX | XXX |
| P/E | — | XXX | 204.7x | XXX | XXX | XXX |
| EV/FCF | — | XXX | 2.6x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified YSB Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
YSB Margins & Growth Rates
YSB's revenue in the last fiscal year grew by 5%.
YSB's revenue per employee in the last FY averaged $0.4M, while opex per employee averaged $0.0M for the same period.
YSB Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | — | XXX | 5% | XXX | XXX | XXX |
| EBITDA Margin | — | XXX | 1% | XXX | XXX | XXX |
| EBITDA Growth | — | XXX | (105%) | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.4M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $0.0M | XXX | XXX | XXX |
| S&M Expenses to Revenue | — | XXX | 8% | XXX | XXX | XXX |
| G&A Expenses to Revenue | — | XXX | 2% | XXX | XXX | XXX |
| R&D Expenses to Revenue | — | XXX | 1% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 11% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
YSB Public Comps
See public comps and valuation multiples for other Pharmacies and Vertical E-commerce comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| YSB | XXX | XXX | XXX | XXX | XXX | XXX |
| Haypp Group | XXX | XXX | XXX | XXX | XXX | XXX |
| Dimed SA | XXX | XXX | XXX | XXX | XXX | XXX |
| Nice One | XXX | XXX | XXX | XXX | XXX | XXX |
| BHG Group | XXX | XXX | XXX | XXX | XXX | XXX |
| JZJ Chain Drugstore | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
YSB M&A Activity
YSB acquired XXX companies to date.
Last acquisition by YSB was on XXXXXXXX, XXXXX. YSB acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by YSB
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialYSB Investment Activity
YSB invested in XXX companies to date.
YSB made its latest investment on XXXXXXXX, XXXXX. YSB invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by YSB
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout YSB
| When was YSB founded? | YSB was founded in 2018. |
| Where is YSB headquartered? | YSB is headquartered in China. |
| How many employees does YSB have? | As of today, YSB has over 6K employees. |
| Who is the CEO of YSB? | YSB's CEO is Buzhen Zhang. |
| Is YSB publicly listed? | Yes, YSB is a public company listed on HKEX. |
| What is the stock symbol of YSB? | YSB trades under 09885 ticker. |
| When did YSB go public? | YSB went public in 2023. |
| Who are competitors of YSB? | YSB main competitors are Haypp Group, Dimed SA, Nice One, BHG Group. |
| What is the current market cap of YSB? | YSB's current market cap is $453M. |
| What is the current revenue of YSB? | YSB's last fiscal year revenue is $3B. |
| What is the current EV/Revenue multiple of YSB? | Current revenue multiple of YSB is 0.1x. |
| Is YSB profitable? | No, YSB is not profitable. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.